HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db07-0742v1 56/10/2420    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robertson, R. P. Search for Related Content PubMed PubMed Citation Articles by Robertson, R. P. Social Bookmarking                What's this?

Estimation of ß-Cell Mass by Metabolic Tests

Necessary, but How Sufficient?

From the Pacific Northwest Research Institute and the Departments of Medicine and Pharmacology, University of Washington, Seattle, Washington

Address correspondence and reprint requests to R. Paul Robertson, Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122. E-mail: rpr{at}pnri.org

Abbreviations: AIR, acute insulin response; AIRarg, AIR to intravenous arginine; AIRgluc, AIR to intravenous glucose; GPAIS, glucose potentiation of arginine-induced insulin secretion; IVAST, intravenous arginine stimulation test; IVGTT, intravenous glucose tolerance test; AIRargMax, glucose potentiation of arginine-induced AIR; OGTT, oral glucose tolerance test; PET, positron emission tomography

This Perspectives in Diabetes addresses the accuracy of metabolic testing as a measure of pancreatic islet ß-cell mass in vivo in animals and in humans. The impetus for framing this question lies in the current intense interest in determining the fate of ß-cell mass in transplanted islets, i.e., does it decrease, increase, or remain the same over time, as well as ascertaining whether drugs that enhance incretin levels, and consequently enhance glucose-induced insulin secretion, might also preserve ß-cell mass. An important methodology recently making scientific strides in this arena is positron emission tomography (PET). The central question this Perspectives in Diabetes raises is whether it is likely that PET will provide significant advantages over the metabolic methods already in hand and routinely used to estimate ß-cell mass. This article examines the fidelity with which published metabolic data correlate with independent measures of ß-cell mass across multiple species. Correlation coefficients in the general range of r = 0.80 are routinely obtained and are robust for in vivo research. Whether PET can significantly improve on these correlations, given its inherent limitations in measurement sensitivity, remains to be seen. It is clear that investigators developing PET methodology to estimate ß-cell mass should at the same time incorporate metabolic measures into their studies so that side-by-side comparisons of the accuracy of the two experimental approaches can be made.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-J. Kim, C. Nian, D. J. Doudet, and C. H.S. McIntosh Inhibition of Dipeptidyl Peptidase IV With Sitagliptin (MK0431) Prolongs Islet Graft Survival in Streptozotocin-Induced Diabetic Mice Diabetes, May 1, 2008; 57(5): 1331 - 1339. [Abstract] [Full Text] [PDF]